IO Biotech Inc IOBT:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/11/22 EDT
3.93quote price arrow up+0.13 (+3.42%)
Volume
12,312
52 week range
3.50 - 17.88
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.93
  • 52 Week High17.88
  • 52 Week High Date11/05/21
  • 52 Week Low3.50
  • 52 Week Low Date07/29/22

Key Stats

  • Market Cap113.26M
  • Shares Out28.82M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-38.59

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.93
  • 52 Week High17.88
  • 52 Week High Date11/05/21
  • 52 Week Low3.50
  • 52 Week Low Date07/29/22
  • Market Cap113.26M
  • Shares Out28.82M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-38.59

RATIOS/PROFITABILITY

  • EPS (TTM)-2.60
  • P/E (TTM)-1.51
  • Fwd P/E (NTM)-1.85
  • EBITDA (TTM)-41.234M
  • ROE (TTM)-
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On IO Biotech Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO...
Peter Hirth Ph.D.
Chairman of the Board
Mai-Britt Zocca Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
Brian Burkavage
Chief Accounting Officer
Address
Ole Maaloes Veh 3
Copenhagen
2200
Denmark

Top Peers

SYMBOLLASTCHG%CHG
ANIX
Anixa Biosciences Inc
3.90+0.08+2.09%
TRVI
Trevi Therapeutics Inc
4.27UNCHUNCH
PYPD
PolyPid Ltd
6.00-0.07-1.23%
PASG
Passage Bio Inc
2.03+0.03+1.50%
CKPT
Checkpoint Therapeutics Inc
1.26+0.03+2.44%